Search Results
Yashasvi Chugh, MD | A 2021 Update on Post PCI Antithrombotic Therapy
Antiplatelet Therapy Post Percutaneous Coronary Intervention by Peter M. Pollak, MD | Preview
Prof. Mehran: Antithrombotic therapy for patients after TAVR, is new oral anticoagulant a new trend?
Prof. Roxana Mehran - Designing trials in antiplatelet therapy – insights from the TWILIGHT trial
Basics of OCT Day 2 Dr Davinder Singh Chadha ABBOTT
Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndrome or PCI
The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI-EuroPCR 2022
Atrial Fibrillation Refresher - A Recap of the Latest Guidelines
Cardio-oncology Discussion: Primary PCI in Cancer Patients
[TCTAP 2021 Virtual] TCTAP Workshop - VI. CHIP
Benefits and Risks of Extended DAPT after DES
Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI
![[TCTAP 2021 Virtual] TCTAP Workshop - VI. CHIP](https://img.youtube.com/vi/iiCNyoGxuvs/hqdefault.jpg)
